ClaritevCTEV +1.88%56 9-Day RSI is 67.29 as of Jul. 01, 2026. GuruFocus rates CTEV with a GF Score™ of 56/100 and a GF Value™ of $31.33 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 700 Healthcare Providers & Services companies, Claritev ranks worse than 83.43% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-01), Claritev's 9-Day RSI is 67.29.
The industry rank for Claritev's 9-Day RSI or its related term are showing as below:
CTEV's 9-Day RSI is ranked worse than 83.43% of 700
companies
in the Healthcare Providers & Services industry
Industry Median: 49.325
vs CTEV: 67.29
Claritev (NYSE:CTEV) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Claritev 9-Day RSI Related Terms
CTEV vs MDRX, EVH, PHR: 9-Day RSI Comparison
For the Health Information Services subindustry, Claritev's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Claritev 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Claritev's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Claritev's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Claritev (CTEV) has a 9-Day RSI of 67.29 as of Jul. 01, 2026. According to the industry distribution chart, Claritev ranks #584 out of 700 companies in the Healthcare Providers & Services industry, placing it in the top 83.4%.
Is Claritev's 9-Day RSI too high?
Claritev's current 9-Day RSI is 67.29. The Healthcare Providers & Services industry median 9-Day RSI is 49.33. Claritev's value of 67.29 is 36.4% above this industry median. Based on the distribution chart, Claritev ranks #584 out of 700 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Claritev has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Claritev's 9-Day RSI compare to MDRX and EVH?
According to the Healthcare Providers & Services industry distribution chart, Claritev ranks #584 out of 700 companies for 9-Day RSI. This places Claritev in the lower half of its industry. The industry median 9-Day RSI is 49.33. Claritev's value of 67.29 is 36.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 49.33, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Claritev's current 9-Day RSI of 67.29 is 36.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 49.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Claritev's current 9-Day RSI is 67.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Claritev stock overvalued right now?
Based on GuruFocus' analysis, Claritev (CTEV) is currently considered Modestly Overvalued. The stock's GF Value™ is $31.33, compared to a current price of $34.75 — trading 10.9% above its estimated fair value. The current 9-Day RSI is 67.29 and 36.4% above the Healthcare Providers & Services industry median of 49.33. Claritev's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Claritev (CTEV), the current 9-Day RSI is 67.29 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Claritev (CTEV) Overvalued in 2026?
Based on GuruFocus' analysis, Claritev stock appears to be overvalued.
The current stock price of $34.75 is trading 10.9% above its estimated GF Value™ of $31.33.
GuruFocus considers Claritev to be Modestly Overvalued.
Key valuation signals for CTEV:
9-Day RSI: 67.29
GF Value™: $31.33 vs. price of $34.75 (10.9% above fair value)
Industry Position: 36.4% above the Healthcare Providers & Services median (#584 of 700)
No single metric tells the full story. See the CTEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
56GF Score
Get the complete analysis for CTEV
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CTEV has been successfully added to your 